首页 | 本学科首页   官方微博 | 高级检索  
     

多周期大剂量化疗辅以外周血干细胞支持对难治性卵巢癌的治疗探索
引用本文:傅士龙,张国玲,李子庭. 多周期大剂量化疗辅以外周血干细胞支持对难治性卵巢癌的治疗探索[J]. 中华肿瘤防治杂志, 2002, 9(3): 363-366
作者姓名:傅士龙  张国玲  李子庭
作者单位:复旦大学附属肿瘤医院妇科,上海,200032
摘    要:卵巢癌的复发和耐药是治疗的重点和难点。目前 ,仍没有较为可靠的治疗手段 ,多周期、大剂量化疗辅以外周血干细胞回输支持 ,作为复发或难治性卵巢癌的巩固或一线治疗方案 ,则能够明显减少大剂量化疗引起的毒副反应 ,缩短化疗周期 ,国外已进行了多中心、多周期、多方案的临床探索 ,有望成为治疗此类卵巢癌的有效方案。

关 键 词:卵巢肿瘤/药物疗法  外周血干细胞
文章编号:1009-4571(2002)03-0363-04
修稿时间:2001-10-22

Multiple Cycles of High-Dose Chemotherapy with Peripheral Blood Stem Cell Support in the Treatment of Relapsed or Refractory Ovarian Cancer
FU Shi long,ZHANG Guo ling,LI Zi ting. Multiple Cycles of High-Dose Chemotherapy with Peripheral Blood Stem Cell Support in the Treatment of Relapsed or Refractory Ovarian Cancer[J]. Chinese Journal of Cancer Prevention and Treatment, 2002, 9(3): 363-366
Authors:FU Shi long  ZHANG Guo ling  LI Zi ting
Affiliation:FU Shi long,ZHANG Guo ling,LI Zi ting. Cancer Hospital of Fudan Univerdity,Shanghai 200032,China
Abstract:Mutiple cycles of high dose chemotherapy with peripheral blood stem cell support as front line treat ment or as consolidation after initial treatment with conventionaldose chemotherapy can achieve high overall and complete response rates in patients with relapsed or refractory ovarian cancer. This technique allow an increase in total and peak doses and decrease the treatment interval to maximize drug delivery and it may become hopeful and effective strategy for such type of ovarian cancer.
Keywords:ovarian neoplasms/drug therapy  peripheral blood stem cell
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号